Nabriva Therapeutics AG | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (15)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: Nikang Raises $200 Million From US And China Investors
Article By: ChinaBio® Today
Saturday, May 29, 2021 1:20 PM EDT
NiKang Therapeutics, a clinical stage Delaware biotech, raised $200 million in a Series C financing from US and China investors. NiKang was originally incubated by CBC Group (C-Bridge Capital) in 2017.
In this article: PFE, INCY, NBRV, 2616.HK, 1801.HK, 1672.HK
Read
The Week Ahead In Biotech: FDA Decisions In The Cards For Merck, Epizyme, Evoke, And Ultragenyx
Article By: Benzinga
Sunday, June 14, 2020 3:13 PM EDT
Biotech stocks came under pressure along with the broader market in the week that ended June 12, as a worsening pandemic situation and its impact on the economy led to an across-the-board sell-off in the global markets.
In this article: MRK, EVOK, RARE, EPZM Also: AZN, GILD, BMY, SNY, RPRX, CELG, PRQR, NBRV, CBIO, UROV, CNTG
Read
Week In Review: BioSense Signs $68 Million China Deal With Neovacs For Therapeutic Vaccine
Article By: ChinaBio® Today
Saturday, February 25, 2017 3:36 PM EDT
BioSense Global, a New Jersey-Suzhou biotech, signed a $68 million option agreement with France's Neovacs for China rights to a therapeutic vaccine aimed at lupus and dermatomyositis.
In this article: NBRV, ABBV, AZN
Read
All Posts

Latest Tweets for $NBRV

No tweets yet!

PARTNER HEADLINES